The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice

Cellular and Molecular Neurobiology

Volumn 16, Issue 1, 1996, Pages 61-72

  Deniselle, Maria Claudia Gonzalez ^a,b   Gonzalez, Susana L ^a,b   Piroli, Gerardo G ^a,b   Lima, Analia E ^a   De Nicola, Alejandro F ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

21 aminosteroid; astrocytes; glial fibrillary acidic protein; spinal cord; U 74389F; Wobbler mice

Indexed keywords

11BETA,17BETA DIHYDROXY 17 (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; 21 AMINOSTEROID; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; DEXAMETHASONE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LAZAROID; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL HYPERPLASIA; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; FEMALE; HYPERTROPHY; MALE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030063311     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02578387     Document Type: Article

References (33)

1. Aizenman, Y., and de Vellis, J. (1987). Synergistic action of thyroid hormone, insulin and hydrocortisone on astrocyte differentiation. Brain Res. 414:301-308.
2. Bracken, M. B., Shepard, M. J., Collins, W. F., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acture spinal cord injury. N. Engl. J. Med. 322:1405-1411.
3. Braughler, J. M., and Hall, E. D. (1984). Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61:290-295.
4. Braughler, J. M., Pregenzer, J. F., Chase, R. L., Duncan, L. A., Jacobsen, E. J. and McCall, J. M. (1987). Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. Biol. Chem. 262:10438-10440.
5. Cohen, G., and Author, A. P. (1982). Pathology of Oxygen, Academic Press, New York.
6. Coirini, H., Magariños, A. M., De Nicola, A. F., Rainbow, T. C., and McEwen, B. S. (1985). Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res. 361:212-216.
7. De Nicola, A. F. (1993). Steroid hormones and neuronal regeneration. In Advances in Neurology (F. J. Seil, Ed.), Raven Press, New York, Vol. 59, pp. 199-206.
8. De Nicola, A. F., Moses, D. F., Gonzalez, S., and Orti, E. (1989). Adrenocorticoid action in the spinal cord: Some unique molecular properties of glucocorticoid receptors. Cell. Mol. Neurobiol. 9:179-192.
9. Duchen, L. W., Falconer, D. S., and Stricht, S. J. (1966). Hereditary progressive neurogenic muscular atrophy in the mouse. J. Physiol. (London) 183:53P-55P.
10. Eddleston, M., and Mucke, L. (1993). Molecular profile of reactive astrocytes-Implications for their role in neurologic disease. Neuroscience 54:15-36.
11. Eng, L. F. (1985). Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8:203-214.
12. Eng, L. F., and Ghirnikar, R. S. (1994). GFAP and astrogliosis. Brain Pathol. 4:229-237.
13. Ferrini, M., Gonzalez, S., Antakly, T., and De Nicola, A. F. (1993). Immunocytochemical localization of glucocorticoid receptors in the spinal cord: Effects of adrenalectomy, glucocorticoid treatment and spinal cord transection. Cell. Mol. Neurobiol. 13:387-398.
14. Fleishaker, J. C., Peters, G. R., and Cathcart, K. S. (1993). Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger. I. Single-dose administration. J. Clin. Pharmacol. 33:175-181.
15. Gage, F. H., Olejniczak, P., and Armstrong, D. M. (1988). Astrocytes are important for sprouting in the septo-hippocampal circuit. Exp. Neurol. 102:2-12.
16. Garcia-Segura, L. M., Liquin, S., Parducz, and Naftolin, F. (1994). Gonadal hormone regulation of glial fibrillary acidic protein immunoreactivity and glial ultrastructure in the rat neuroendocrine hypothalamus. Glia 10:59-69.
17. Giulian, D., and Corpuz, M. (1993). Microglial secretion products and their impact on the nervous system. In Advances in Neurology (F. J. Seil, Ed.), Raven Press, New York, Vol. 59, pp. 315-320.
18. Goss, J. R., Finch, C. E., and Morgan, D. G. (1991). Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol. Aging 12:165-170.
19. Hall, E. D. (1987). Beneficial effects of the 21-aminosteroid U-74006F in acute CNS trauma and hypovolemic shock. Acta Anaesth. Belg. 38:421-425.
20. Hall, E. D. (1993). Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell. Mol. Neurobiol. 13:415-432.
21. Krieger, C., Perry, T. L., Hanse, S., Mitsumoto, H., and Honore, T. (1992). Excitatory amino acid receptor antagonist in murine motoneurone disease (the Wobbler mouse). Can. J. Neurol. Sci. 19:462-465.
22. Kupersmith, M. J., Kaufman, D., Paty, D. W., Ebers, G., McFarland, H., Johnson, K., Reingold, S., and Whitaker, J. (1994). Megadose corticosteroids in multiple sclerosis. Neurology 4:1-4.
23. Laage, S., Zobel, G., and Jockusch, H. (1988). Astrocyte overgrowth in the brain stem and spinal cord of mice affected by spinal atrophy, Wobbler. Dev. Neurosci. 10:190-198.
24. La Mantia, L., Eoli, M., Milanese, C., Salmaggi, A., Dufour, A., and Torri, V. (1994). Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur. Neurol. 34:199-203.
25. taping, N. J., Nichols, N. R., Day, J. R., and Finch, C. E. (1991). Corticosterone differentially regulates the bilateral response of astrocyte mRNAs in the hippocampus to entorhinal cortex lesions in male rats. Mol. Brain Res. 10:291-297.
26. Laping, N. J., Teter, B., Nichols, N. R., Rozovsky, I., and Finch, C. E. (1994). Glial fibrillary acidic protein: Regulation by hormones, cytokines, and growth factors. Brain Pathol. 1:259-275.
27. Leetsma, J. E. (1980). Animal model: Motor neuron disease in the wobbler (wr/wr) mouse. Am. J. Pathol. 100:811-814.
28. McCall, J. M., Hall, E. D., and Braughler, J. M. (1989). A new class of 21-aminosteroids which are useful for stroke and trauma. In Steroids and Diseases of the Central Nervous System (R. Capildeo, Ed.), John Wiley & Sons, New York, pp. 69-80.
29. McKeon, R. J., Schreiber, R. C., Rudge, J. S., and Silver, J. (1991). Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11:3398-3411.
30. Mitsumoto, H., and Bradley, W. G. (1982). Murine motor neuron disease (the Wobbler Mouse): Degeneration and regeneration of the lower motor neuron. Brain Res. 105:811-834.
31. Moses, D. F., Gonzalez, S., McEwen, B. S., and De Nicola, A. F. (1991). Glucocorticoid type II receptors of the spinal cord show lower affinity than hippocampal type II receptors. Binding parameters obtained with different experimental protocols. J. Steroid Biochem. Mol. Biol. 39:5-12.
32. Muller, H. W., Matthiessen, H. P., Schmalenbach, C., and Schroeder, W. O. (1991). Glial support of CNS neuronal survival, neurite growth and regeneration. Rest. Neurol. Neurosci. 2:229-232.
33. Murayama, S., Inoue, K., Kawakami, H., Bouidin, T. W., and Suzuki, K. (1991). A unique pattern of astrocytosis in the primary motor area in amyotrophic lateral sclerosis. Acta Neuropathol. (Berlin) 82:456-461.